Harmon Cyrus L.'s most recent trade in Olema Pharmaceuticals Inc was a trade of 24,150 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 24,150 | 24,150 | - | - | Stock Option (right to buy) | |
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2024 | 29,250 | 780,533 | - | 0 | Common Stock | |
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director | Sale of securities on an exchange or to another person at price $ 9.37 per share. | 09 Dec 2024 | 8,256 | 772,277 | - | 9.4 | 77,359 | Common Stock |
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director | Sale of securities on an exchange or to another person at price $ 8.66 per share. | 09 Dec 2024 | 7,958 | 764,319 | - | 8.7 | 68,916 | Common Stock |
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director | Sale of securities on an exchange or to another person at price $ 9.39 per share. | 09 Dec 2024 | 179 | 764,140 | - | 9.4 | 1,681 | Common Stock |
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director | Sale of securities on an exchange or to another person at price $ 15.58 per share. | 29 Jul 2024 | 4,066 | 752,217 | - | 15.6 | 63,348 | Common Stock |
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director | Sale of securities on an exchange or to another person at price $ 15.55 per share. | 29 Jul 2024 | 934 | 751,283 | - | 15.6 | 14,524 | Common Stock |
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director | Sale of securities on an exchange or to another person at price $ 12.26 per share. | 11 Jul 2024 | 5,000 | 756,283 | - | 12.3 | 61,300 | Common Stock |
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director | Sale of securities on an exchange or to another person at price $ 10.77 per share. | 28 Jun 2024 | 20,000 | 761,283 | - | 10.8 | 215,400 | Common Stock |
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 23,000 | 23,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director | Sale of securities on an exchange or to another person at price $ 9.41 per share. | 31 May 2024 | 15,000 | 791,283 | - | 9.4 | 141,150 | Common Stock |
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director | Sale of securities on an exchange or to another person at price $ 12.33 per share. | 31 May 2024 | 5,000 | 781,283 | - | 12.3 | 61,650 | Common Stock |
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director | Sale of securities on an exchange or to another person at price $ 10.93 per share. | 31 May 2024 | 5,000 | 786,283 | - | 10.9 | 54,650 | Common Stock |
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director | Sale of securities on an exchange or to another person at price $ 10.92 per share. | 06 May 2024 | 5,000 | 806,283 | - | 10.9 | 54,600 | Common Stock |
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director | Sale of securities on an exchange or to another person at price $ 9.51 per share. | 30 Apr 2024 | 15,000 | 811,283 | - | 9.5 | 142,650 | Common Stock |
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director | Sale of securities on an exchange or to another person at price $ 10.97 per share. | 28 Mar 2024 | 20,000 | 826,283 | - | 11.0 | 219,400 | Common Stock |
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director | Sale of securities on an exchange or to another person at price $ 12.41 per share. | 29 Feb 2024 | 24,900 | 846,383 | - | 12.4 | 309,009 | Common Stock |
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 29 Feb 2024 | 100 | 846,283 | - | 13 | 1,300 | Common Stock |
| Olema Pharmaceuticals Inc | L. Cyrus Harmon | Director | Sale of securities on an exchange or to another person at price $ 12.23 per share. | 31 Jan 2024 | 25,000 | 876,283 | - | 12.2 | 305,750 | Common Stock |
| Olema Pharmaceuticals Inc | Harmon Cyrus L. | Director | Sale of securities on an exchange or to another person at price $ 15.56 per share. | 31 Jan 2024 | 5,000 | 871,283 | - | 15.6 | 77,800 | Common Stock |
| Olema Pharmaceuticals Inc | Cyrus Harmon L. | Director | Sale of securities on an exchange or to another person at price $ 13.30 per share. | 29 Dec 2023 | 22,500 | 903,783 | - | 13.3 | 299,250 | Common Stock |
| Olema Pharmaceuticals Inc | Harmon L. Cyrus | Director | Sale of securities on an exchange or to another person at price $ 14.10 per share. | 29 Dec 2023 | 2,500 | 901,283 | - | 14.1 | 35,250 | Common Stock |
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director | Sale of securities on an exchange or to another person at price $ 12.57 per share. | 30 Nov 2023 | 25,000 | 926,283 | - | 12.6 | 314,250 | Common Stock |
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2023 | 15,750 | 959,464 | - | 0 | Common Stock | |
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director | Sale of securities on an exchange or to another person at price $ 14.86 per share. | 20 Nov 2023 | 4,192 | 955,272 | - | 14.9 | 62,293 | Common Stock |
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director | Sale of securities on an exchange or to another person at price $ 13.90 per share. | 20 Nov 2023 | 3,989 | 951,283 | - | 13.9 | 55,447 | Common Stock |
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director | Sale of securities on an exchange or to another person at price $ 12.05 per share. | 31 Oct 2023 | 25,000 | 948,714 | - | 12.1 | 301,250 | Common Stock |
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director | Sale of securities on an exchange or to another person at price $ 15.64 per share. | 31 Oct 2023 | 5,000 | 943,714 | - | 15.6 | 78,200 | Common Stock |
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director | Sale of securities on an exchange or to another person at price $ 12.41 per share. | 29 Sep 2023 | 25,000 | 973,714 | - | 12.4 | 310,250 | Common Stock |
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director | Sale of securities on an exchange or to another person at price $ 9.36 per share. | 31 Aug 2023 | 15,000 | 1,008,714 | - | 9.4 | 140,400 | Common Stock |
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director | Sale of securities on an exchange or to another person at price $ 11.62 per share. | 31 Aug 2023 | 10,000 | 998,714 | - | 11.6 | 116,200 | Common Stock |
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director | Sale of securities on an exchange or to another person at price $ 10.14 per share. | 16 Aug 2023 | 15,000 | 1,023,714 | - | 10.1 | 152,100 | Common Stock |
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director | Sale of securities on an exchange or to another person at price $ 10.14 per share. | 16 Aug 2023 | 15,000 | 1,023,714 | - | 10.1 | 152,100 | Common Stock |
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director | Sale of securities on an exchange or to another person at price $ 6.30 per share. | 08 Jun 2023 | 10,000 | 1,038,714 | - | 6.3 | 63,000 | Common Stock |
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director | Sale of securities on an exchange or to another person at price $ 6.30 per share. | 05 Jun 2023 | 5,000 | 1,048,714 | - | 6.3 | 31,475 | Common Stock |
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director | Sale of securities on an exchange or to another person at price $ 6.04 per share. | 05 Jun 2023 | 5,000 | 1,053,714 | - | 6.0 | 30,225 | Common Stock |
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director, Chief Research Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director, CHIEF TECHNOLOGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 104,500 | 104,500 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director, CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 24.76 per share. | 29 Nov 2021 | 400 | 1,051,146 | - | 24.8 | 9,904 | Common Stock |
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director, CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 27.85 per share. | 19 Oct 2021 | 7,445 | 1,056,101 | - | 27.8 | 207,343 | Common Stock |
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director, CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 28.20 per share. | 19 Oct 2021 | 4,555 | 1,051,546 | - | 28.2 | 128,451 | Common Stock |
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director, CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 26.30 per share. | 20 Sep 2021 | 12,000 | 1,063,546 | - | 26.3 | 315,600 | Common Stock |
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director, CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 24.83 per share. | 20 Jul 2021 | 7,877 | 1,091,669 | - | 24.8 | 195,586 | Common Stock |
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director, CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 25.63 per share. | 20 Jul 2021 | 4,123 | 1,087,546 | - | 25.6 | 105,672 | Common Stock |
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director, CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 24.54 per share. | 18 Jun 2021 | 9,410 | 1,102,136 | - | 24.5 | 230,921 | Common Stock |
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director, CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 25.59 per share. | 18 Jun 2021 | 1,990 | 1,100,146 | - | 25.6 | 50,924 | Common Stock |
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director, CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 26.30 per share. | 18 Jun 2021 | 600 | 1,099,546 | - | 26.3 | 15,780 | Common Stock |
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director, Chief Technology Officer | 23 Nov 2020 | 122,028 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director, Chief Technology Officer | 23 Nov 2020 | 122,028 | 122,028 | - | - | Common Stock | ||
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director, Chief Technology Officer | 23 Nov 2020 | 71,374 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Olema Pharmaceuticals Inc | Cyrus L. Harmon | Director, Chief Technology Officer | 23 Nov 2020 | 71,374 | 1,111,546 | - | - | Common Stock |